- Home
- FDMT vs ALTS Comparison
FDMT vs ALTS Comparison
Compare FDMT & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- ALTS
- Stock Information
- Founded
- FDMT 2013
- ALTS 1976
- Country
- FDMT United States
- ALTS United States
- Employees
- FDMT N/A
- ALTS N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- ALTS
- Sector
- FDMT Health Care
- ALTS
- Exchange
- FDMT Nasdaq
- ALTS NYSE
- Market Cap
- FDMT 192.2M
- ALTS 159.4M
- IPO Year
- FDMT 2020
- ALTS N/A
- Fundamental
- Price
- FDMT $4.38
- ALTS $6.96
- Analyst Decision
- FDMT Buy
- ALTS
- Analyst Count
- FDMT 10
- ALTS 0
- Target Price
- FDMT $32.33
- ALTS N/A
- AVG Volume (30 Days)
- FDMT 410.7K
- ALTS 298.9K
- Earning Date
- FDMT 08-07-2025
- ALTS 08-18-2025
- Dividend Yield
- FDMT N/A
- ALTS N/A
- EPS Growth
- FDMT N/A
- ALTS N/A
- EPS
- FDMT N/A
- ALTS N/A
- Revenue
- FDMT $23,000.00
- ALTS $18,046,000.00
- Revenue This Year
- FDMT $13,048.65
- ALTS $185.91
- Revenue Next Year
- FDMT N/A
- ALTS $64.93
- P/E Ratio
- FDMT N/A
- ALTS N/A
- Revenue Growth
- FDMT N/A
- ALTS N/A
- 52 Week Low
- FDMT $2.24
- ALTS $1.29
- 52 Week High
- FDMT $28.93
- ALTS $10.95
- Technical
- Relative Strength Index (RSI)
- FDMT 56.61
- ALTS 40.74
- Support Level
- FDMT $4.23
- ALTS $7.06
- Resistance Level
- FDMT $4.50
- ALTS $8.15
- Average True Range (ATR)
- FDMT 0.26
- ALTS 0.92
- MACD
- FDMT 0.01
- ALTS -0.19
- Stochastic Oscillator
- FDMT 85.37
- ALTS 9.04
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.